• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Envigo appoints Hardy president and CEO, Cass executive chairman

Envigo appoints Hardy president and CEO, Cass executive chairman

June 27, 2016
CenterWatch Staff

Envigo has announced that its board of directors has appointed Dr. Adrian Hardy as president and chief executive officer, effective July 1. He will join the company’s board of directors. Dr. Hardy joined Envigo in 2002 and has held various roles of increasing responsibility in sales, strategic marketing and operations, most recently serving as COO. 

In related moves, Brian Cass, the previous CEO, will become executive chairman, and Andrew Baker, the previous chairman, will become chairman emeritus and remain a board member. These changes also are effective July 1.

Adrian Hardy said, “I’m delighted and extremely proud to be taking on this role at such an exciting time for Envigo and the research community. I’ve worked closely with Andrew and Brian during my time with the company and would like to thank them for their contributions to making Envigo the world class company it is today. Their vision and leadership has positioned our company as a market leader, and I look forward to continuing to work with them in their new roles as we strive to build on the growth and success of Envigo.”

Brian Cass said, “In the 18 years that I have had the privilege to lead our company I have witnessed great, and positive changes within life science research and in our company. Envigo has truly come of age and is now a crucial partner to our customers in the conduct of their research and the development of their life-changing products. I am enthusiastic that the skills, experience, and passion that Adrian brings to the role of CEO positions him to successfully lead Envigo to the next level in its development. I believe he will be a great and imaginative leader, and I look forward to continuing to work with him and the rest of the board.”

Dr. Hardy holds a BSc in human biology from King’s College London and a Ph.D. in developmental biology from University College London.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing